Your SlideShare is downloading. ×
Stage 4 Cancer Strategies That Truly Make a DifferenceStage 4 Cancer Strategies That Truly Make a DifferenceResearch on an...
dollar pharmaceutical industry and doctors like Folkan and Ingber, should receive far greatercommendation for their works ...
that a tumor, by nature, will detest. Creating an environment that naturally repels stage 4 cancer is acritical method by ...
Upcoming SlideShare
Loading in...5
×

Stage 4 Cancer Strategies That Truly Make a Difference

225

Published on

http://www.envita.com/conditions-we-treat/cancer/stage-4cancer/ - Stage 4 Cancer is also known as Stage IV Cancer, which spread to various sites in the body. It is a complex type of cancer to treat, and it can involve many organ systems. Envita’s vast area of technologies options gives stage 4 cancer patients the most complete approach to their cancer.

Published in: Health & Medicine, Technology
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
225
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Transcript of "Stage 4 Cancer Strategies That Truly Make a Difference"

  1. 1. Stage 4 Cancer Strategies That Truly Make a DifferenceStage 4 Cancer Strategies That Truly Make a DifferenceResearch on angiogenesis for stage 4 cancer – the method by which tumors attract blood vessels tonourish themselves was begun by Dr. Judah Folkman, who determined that a tumor placed in a labcontainer had a limited potential for growth. Moreover, he established that the micro vascular network forthe cancer could be disrupted.Like so many great scientific minds with a new idea, Folkman was often ignored by his colleagues andpeers. While it should be said that many agreed there was evidence of newly formed vessels – thedissenting assumption was that the detected inferior cell networks were merely a byproduct of dyingtumor cells. Some years later Folkman could prove that they, in fact, were actually being created by thecancer cells as a means to deliver them there much-needed nutrients.Now consider this for a moment. The United States Government website HealthReport.gov contends that,“Nearly one out of two Americans born today will be diagnosed with cancer at some point in their lifetime.About 1,596,670 new cancer, cases are expected to be diagnosed in 2011 – and about 571,950Americans are expected to die of cancer, more than 1,500 people a day – and cancer is the second mostcommon cause of death in the US, exceeded only by heart disease. In the US, cancer alone accounts fornearly 1 of every 4 deaths." Stage 4 cancer patients are also growing in number due to late diagnosisand often non effect treatment methods.With such a destructive epidemic facing us, one would think that new ideas and innovation would bewelcomed with open arms. Nevertheless, we regularly and have even come to expect the all-to-familiarpattern of contempt for ground-breaking innovators and thinkers.In another example, devoted researcher Dr. Don Ingber was studying endothelial cells when one of histest samples became contaminated with a fungus. He was amazed to see that in the presence of thisfungus, the cells actually stopped growing. As fate would have it, Ingber’s original position thatangiogenesis could be inhibited was ultimately supported. Today anti-angiogenic drugs are a multibillion-
  2. 2. dollar pharmaceutical industry and doctors like Folkan and Ingber, should receive far greatercommendation for their works – rather than the usual condemnation. Many o of these anti-angiogenicchemotherapeutic drugs are used to manage stage 4 cancer patients.Anti-angiogenic drugs such as sorafenib (Nexavar®), sunitinib (Sutent®), pazopanib (Votrient®), andeverolimus (Afinitor®) are typically prescribed in late-stage cancers in order to slow growth. However, asimple agent like oxygen (non patentable) is an often overlooked for the dominant anti-angiogenic agentthat it is. In fact, oxygen metabolism errors are involved in the cause and development of many cancers.These strategies culminate with more than a decade of combining conventional and advanced naturalapproaches to treat cancer. Understanding the role of oxygen and using is correctly is vital for success,particularly when treating stage 4 cancer.In light of such grim aforementioned statistics, it is imperative that we must work collectively and withopen minds to defeat the venerable adversary called cancer and provided better methods for tacklingstage 4 cancer.Through all of the struggles some bright lights have emerged – and perhaps this one has its place amongthe brightest - anti-antiogenic therapy. In simple terms, it is designed to starve stage 4 cancer from muchneeded nutrients thereby blocking its development, growth, and spread.This is revolutionary when one considers that 90 percent of cancer patients succumb to their diseasebecause their cancer has spread beyond its original site (metasized) – the picture of stage 4 cancerdiagnosis. The fact that we may now inhibit tumor angiogenesis – is a quantum leap for treatmentprotocols.While such treatments are viewed as being in their fledgling states by conventional institutions, Envita hasalready realized stunning success with them. In fact, it has been found that integrating these anti-angiogenic methods with traditional chemotherapy and radiation can work synergistically with the bodyand produce impressive results. These methods seem to be very helpful for advanced stage 4 cancerpatients as well.Because of the incredible threat it imposes, there is no question that angiogenesis should be blocked tostop tumor growth. In fact, without it, tumor growth is limited to a miniscule 2 mm in size. Envita’sspecifically designed cancer therapies work by shutting off nutrients to the tumors and ultimately destroythe cancer cells that rely on them.In addition to this approach a protein known as VEGF (*vascular endothelial growth factor) has beenidentified as the agent that stimulates angiogenesis. It has been found that a tumor releases VEGF for avariety of factors - one of which is triggered by a lack of oxygen, or hypoxia. This process is brought intobeing by the transcriptional factor HIF-1 (hypoxia inducible factor 1).One thing we can count on is that a tumor will always attempt to grow, even beyond the support of itsexisting blood supplies. As a result there is always a need for hypoxic tissue on the tumor so it can createmore VEGF. That alone is enough to suggest to Envita that correcting a tumor’s oxygen metabolism willlikely yield positive results.You see, without VEGF tumors simply cannot grow or spread. By introducing reactive oxygen species, itis possible to potentiate other cancer treatments as they stimulate a change from anaerobic to aerobic
  3. 3. that a tumor, by nature, will detest. Creating an environment that naturally repels stage 4 cancer is acritical method by which to facilitate and maintain remission.But how can this be done effectively?Well, VEGF has been shown to bind to certain cells, called endothelials, of the nearby blood vessels.These cells diverge and grow in the direction of the tumor forming new, albeit inferior blood vessels thatactually rely on VEGF to survive. As fate would have it, they are not as difficult as one might think todetect. So, the goal then becomes targeting and destroying these rogue vessels while bolstering healthyones. The end result accelerates energy, cardiovascular stamina, and the patient’s overall endurance.It has been determined that VEGF is connected to a broad series of tumor types, including breast,ovarian, cervical, esophageal, lung, and cervical cancer, as well as glioblastoma multiforme and renal cellcarcinoma. It would seem that VEGF emissions may also hinder the immune system’s ability to react andfight off the tumor - regularly occurring in stage 4 cancers.Remember, the immune system is our first and last defense against stage 4 cancers. While many patientsbelieve that their cancer has been destroyed they often find out that dormant metastasis was biding itstime to strike. We can however attempt to thwart its efforts by correcting the body’s oxygen metabolism –thereby stopping angiogenesis in its tracks.If you know anyone who has been diagnosed with cancer or has stage 4 cancer, please forward thisarticle to them. We at Envita welcome you to contact us with questions and invite you to watch ourinformative videos. You can also visit our PPMR section to learn more about the power of ourpersonalized medicine for cancer and chronic diseases. It is important information that may save lives.Education is the best prescription.Take advantage of Envita’s Comprehensive Smart Oncology (link to Envita.com cancer section)which incorporates the foremost treatment approaches and synchronizes them with aggressive naturaltherapies to help each patient far greater results. Visit Envita’s stage 4 cancer (link to Envita cancersection) therapies and strategies.References:*Judah Folkman <http://www.pbs.org/wgbh/nova/body/cancer-warrior.html > , <http://en.wikipedia.org/wiki/Judah_Folkman > *Stage 4 Cancer < http://en.wikipedia.org/wiki/Stage-4_cancer#Systems_of_staging > * Vascular endothelial growth factor<http://en.wikipedia.org/wiki/Vascular_endothelial_growth_factor>*HealthReform.gov<http://www.healthreform.gov/reports/fightingcancer/index.html>*American Cancer Society<http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-029771.pdf>

×